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INTRODUCTION  
Milk-alkali syndrome is characterized by the triad of 
hypercalcemia, metabolic alkalosis and acute renal 
failure and is associated with the intake of large 
amounts of calcium and absorbable alkali.1,2 Possible 
symptoms of hypercalcemia include debility and 
fatigue, muscle weakness, concentration disorders, 
nausea, vomiting, anorexia, constipation, polyuria, 
polydipsia, depressed mood, hypertension, arrhythmia 
and somnolence.3 Aged females taking calcium 
carbonate supplements for osteoporosis or other 
reasons are too vulnerable to hypercalcemia. Milk alkali 
syndrome first was first identified in the beginning of 
20th century. With the introduction  of  H2 blockers  and 
proton  pump  inhibitors,  the  incidence of Milk-alkali 
syndrome decreased, but a resurgence of this syndrome 
has been witnessed because of the wide availability and 
increasing use of calcium supplements. 
 
CASE REPORT 
A 79-year-old female patient was referred by her family 
physician to evaluate her hypercalcemia. On admission, 
the patient complained of confusion, anorexia, nausea, 
polyuria, weakness in arms and legs, nausea and 
alternating stool consistency. Increasing forgetfulness 
in the past 2 weeks was reported by the accompanying 
person. Vital signs were in normal range, the patient 
was well oriented to place and time and no neurological 
deficits were noticed. Laboratory tests confirmed the 
presence of hypercalcemia at 2.8 mmol/L. Calcium 
levels at the family physician’s clinic two days before 
were 3.5 mmol/L. The dose of the diuretic was increased 
in view of cardiac decompensation a few days before the  
 
 
 
occurrence of hypercalcemia with a simultaneous 
increase in calcium supplementation. Other routine 
blood parameters were notable for increased creatinine 
at 158 pmol/L. The ECG, chest X-ray and urine 
examination were all normal. At the time of admission, 
patient was taking acetylsalicylic acid, lisinopril, 
furosemide, atorvastatin, calcium carbonate 
supplements and vitamin D. Parathyroid hormone 
levels were found to be low, excluding PTH-mediated 
hypercalcemia as well as primary hyperparathyroidism. 
Laboratory tests revealed reduced 1.25-OH-Vitamin D3. 
 
Evidence of respiratory alkalosis was found on 
performing arterial blood gas analysis with a 
compensatory increase in carbon dioxide partial 
pressure. Further investigation revealed an increase in 
the bicarbonate levels. Calcium and vitamin D 
supplementation were stopped, diuretic therapy was 
discontinued and forced hydration was started for the 
treatment of hypercalcemia. Calcium levels the 
following day to 2.53 mmol/L and the patient reported 
a reduction in level of nausea, fatigue, weakness and 
polyuria. As calcium levels lowered down to normal and 
remained in range after forced hydration, malignancy 
or a paraneoplastic cause were excluded. Vitamin D 
intoxication was also ruled out as 25-hydroxy vitamin 
D3 levels were in normal range. There was no evidence 
indicating pathological conditions like granulomatous 
diseases, sarcoidosis, tuberculosis or lymphomas. 
Hyperfunctioning thyroid and Adrenocortical 
insufficiency were also excluded on basis of normal TSH 
values   (along   with   absent  classic    hyperthyroidism  
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symptoms) and normal morning cortisol levels 
respectively. The congenital metabolic disorder of 
familial hypocalciuric hypercalcemia was ruled out on 
cross confirming the patient’s previous checkup reports 
from family physician. High level of creatinine (167 
μmol/L) and low glomerular filtration rate (24 
mL/min/1.73 m2) suggesting an acute renal failure 
noted in addition to hypercalcemia and metabolic 
alkalosis lead to a diagnosis of milk-alkali syndrome. 
 
DISCUSSION 
Increased calcium levels are challenging for physicians 
and non-specific symptoms are problematic.3 The 
search for a definite diagnosis is essential in view of the 
diverse treatment options. In hypercalcemic subjects, it 
is important to confirm the laboratory values with a 
second blood sample and correcting it against the 
serum albumin. This helps in ruling out pseudo-
hypercalcemia occurring due to dehydration or other 
causes and helps in formulation of a correct diagnosis. 
Increased calcium is confirmed by a second blood 
sample and PTH determined simultaneously. Past 
medical history and records are also helpful in assessing 
the dynamics of the metabolic disorder. Majority of 
cases of hypercalcemia are due to primary 
hyperparathyroidism or a (para)neoplastic cause. A 
detailed drug history and evaluation of 25-OH-vitamin 
D3 and 1,25-OH-vitamin D3, blood gas analysis, PTHrP 
and thyroid stimulating hormone are helpful in 
evaluating PTH-independent hypercalcemia. 
 
Milk-alkali syndrome consists of hypercalcemia, 
various degrees of renal failure, and metabolic alkalosis 
due to ingestion of large amounts of calcium and 
absorbable alkali. This syndrome was first identified 
after medical treatment of peptic ulcer disease with 
milk and alkali was widely adopted during early 20th 
century [4]. Other differential diagnostic etiologies for 
hypercalcemia must also be excluded. When H2 
blockers and proton-pump inhibitors were introduced 
for medical use, there was a decrease in the incidence 
of milk-alkali syndrome. Milk alkali syndrome is 
reported to be the third most common cause of 
hypercalcemia after hyperparathyroidism and 
malignant neoplasms.5,6 The commonly affected 
subjects have comorbid conditions or risk factors like 
elderly women taking calcium supplements for 
osteoporosis, subjects with chronic renal disease, 
people at high risk for volume depletion and people 
who use calcium supplements or antacids at high doses 
or drugs that may reduce the glomerular filtration rate.3  
Hypercalcemia causes renal vasoconstriction with 
reduced GFR. The activation of calcium-sensing 
receptors in the ascending limb of the loop of Henle 
slows down sodium-potassium-chloride transporters, 
resulting in increased natriuresis and diuresis leading to 
a fluid deficit. Hypercalcemia also slows down ADH-
dependent water reabsorption, which leads to further 
volume depletion and further reduces pre-renal 
glomerular filtration. Intake of absorbable alkalis, 
impaired renal function, and increased tubular 
bicarbonate absorption require and maintain metabolic 
alkalosis, which in turn leads to calcium reabsorption 
via a pH-sensitive calcium channel in the distal tubule, 
thereby maintaining hypercalcemia. Evidence based 
therapy consists of cessation of all calcium- and 
carbonate-containing or alkaline preparations and 
definite forced hydration at the start with calcium-free 
infusion solutions. Immediate administration of 
calciuric loop diuretics is not recommended since they 
may result in an electrolyte imbalance, hypovolemia or 
renal impairment.1 The possible use of loop diuretics 
after rehydration should be assessed clinically based on 
volume status. Calcium-sparing diuretics are 
contraindicated. Bisphosphonates should not be used 
due to the high risk of consequent hypocalcemia with 
milk-alkali syndrome. Calcium levels returning to 
normal within a few days and remaining normal also 
indicates the presence of milk-alkali syndrome. 
 
Evidence in the literature suggests that pure metabolic 
alkalosis may be absent in cases with pre-existing 
chronic renal failure.7 It was suspected that suspending 
calcium carbonate intake and reducing diuretics in 
consultation with the family physician before referral 
interrupted the vicious circle of hypercalcemia, leading 
to reduction metabolic alkalosis and regression of 
hypercalcemia. 
 
CONCLUSION 
The presence of non-specific symptoms such as nausea, 
fatigue, low threshold serum calcium and albumin-
corrected calcium levels calculated should direct the 
healthcare professionals to take hypercalcemia into 
consideration. Detailed drug intake history and PTH 
measurement helps in formulating initial diagnosis of 
hypercalcemia. There are numerous causes of 
hypercalcemia like multiple myeloma, thyrotoxicosis, 
primary hyperparathyroidism, malignant neoplastic 
lesions and calcium or vitamin D intoxication. Milk-
alkali syndrome should be considered if hypercalcemia, 
alkalosis and acute renal failure are present.  
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